Statistics

Total Visits

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).11

Select a period of time:

Number of views in the range

Views
Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).6

Views

Views
December 20231
January 20240
February 20241
March 20241
April 20240
May 20243
June 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
Spain1
 

Top cities views

Views
Ashburn2
Chicago1
Seville1